Intellia Therapeutics (NASDAQ: NTLA) was lifted to Outperform from Market Perform by BMO Capital Markets analyst Kostas Biliouris on Monday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE